A study by Villacorta et al. on 111 AAV Spanish patients (including 58 with renal limited vasculitis) found a low proportion of 8.1% of patients with a low C3 level at diagnosis, which is close to that of our study. This evidence concerns the gene C3 and anti-neutrophil cytoplasmic antibody-associated vasculitis.